Chinese contract research organization (CRO) Hangzhou Tigermed Consulting is joining hands with Singapore’s state-owned investment firm Temasek Holdings Limited to launch a USD-denominated investment fund that will back early and growth-stage startups in the biotechnology and CRO fields.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
